- Category
- Medium (2023-24)
- Udyam number
- UDYAM-HP-11-0001739

About Curetech Formulations Private Limited
Data last updated:
Curetech Formulations Private Limited is a private limited company based in Shimla, Himachal Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 August 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Himachal Pradesh, under CIN U24232HP2003PTC026326. Its GSTIN is 02AACCC4441N1ZU (Himachal Pradesh). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹16 Lakh and a paid-up capital of ₹15.3 Lakh. It is led by directors Sumit Kumar (Whole-Time Director) and Ashwani Kumar (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Vill Juddi Kalanjyothi Laboratories Baddi Distt Solan, Shimla, Himachal Pradesh, India – 171001.
As per the financials filed for FY 2024, the company reported a revenue of ₹83.74 Cr, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹68.84 Lakh (net margin 0.8%) and EBITDA of ₹3.92 Cr (EBITDA margin 4.7%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years and 11% over five years.
The company has about 405 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹30.1 Cr and satisfied charges of ₹18.11 Cr on record. Court records list 8 cases involving the company, including 4 filed by the company and 4 filed against it; 2 cases are pending. The company has 1 deal on record (1 secondary share transfer); the latest was in December 2006. Its 7 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 3 smaller; the largest is Nava Healthcare Private Limited with revenue of ₹84.21 Cr.
Curetech Formulations Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-HP-11-0001739). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website curetechformulations.com.
Company details
Recognitions & Rankings of Curetech Formulations
Contact details
Curetech Formulations Private Limited's registered office is in Shimla, Himachal Pradesh. Its website is curetechformulations.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressVill Juddi Kalanjyothi Laboratories Baddi Distt Solan, Shimla, Himachal Pradesh, India – 171001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Curetech Formulations Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Curetech Formulations is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Curetech Formulations Private Limited, buy the company report.
Financials of Curetech Formulations Private Limited
FY 2024 filings availableCuretech Formulations Private Limited reported revenue of ₹83.74 Cr (up 4% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 4% growth in the latest year. EBITDA rose 30% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹83.74 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.92 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹68.84 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.7% | ||||
| Net Profit Margin | 0.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Curetech Formulations Private Limited, buy the company report.
Board of directors of Curetech Formulations Private Limited
Curetech Formulations has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sumit Kumar Also directs: Curetech Pharma Private Limited | Whole-Time Director | 01 Aug 2006 | 20 Years 3 Months | Current |
| Ashwani Kumar Also directs: Medira Healthcare Limited, Nextmile Industries Private Limited, CSC Pharmaceuticals Private Limited and 2 more | Whole-Time Director | 29 Aug 2003 | 23 Years 2 Months | Current |
Peer comparison
Curetech Formulations Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nava Healthcare Private Limited | ₹84.21 Cr (FY 2025) | 2.0% | New Delhi, Delhi, India | |||
| Inchem Laboratories Private Limited | ₹84.08 Cr (FY 2025) | 12.0% | Hyderabad, Telangana, India | |||
| Macmillon Pharmaceuticals Private Limited | ₹83.91 Cr (FY 2024) | 50.0% | Punjab, India | |||
| Sunbeam Lifesciences Private Limited | ₹83.83 Cr (FY 2025) | 25.0% | Puducherry, India | |||
| Curetech Formulations Private Limitedthis company | ₹83.74 Cr (FY 2024) | ₹68.84 Lakh | 0.8% | 4.0% | 405 | Shimla, Himachal Pradesh, India |
| Wexford Laboratories Private Limited | ₹83.63 Cr (FY 2024) | 22.0% | Tumkur, Karnataka, India | |||
| J Duncan Healthcare Private Limited | ₹82.47 Cr (FY 2025) | -57.0% | Shahapur, Maharashtra, India | |||
| Maxheal Pharmaceuticals (India) Limited | ₹82.41 Cr (FY 2024) | 10.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Curetech Formulations Private Limited, buy the company report.
Auditor
Curetech Formulations Private Limited is audited by JAIN & ANIL SOOD for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JAIN & ANIL SOOD | FY 2024 | 010505N |
Shareholding
The shareholding of Curetech Formulations Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Curetech Formulations Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Oct 2025 | 101179234 | Others | ₹2 Cr | Open | |
| 27 Aug 2025 | 101151271 | Others | ₹96.9 Lakh | Open | |
| 07 Jul 2025 | 101127022 | Sidbi | ₹1.72 Cr | Open | |
| 18 May 2024 | 100940237 | Others | ₹9.5 Lakh | Open | |
| 13 Feb 2024 | 100872517 | Others | ₹3.25 Cr | Open |
To see the full charge records of Curetech Formulations Private Limited, buy the company report.
Total charge records: 26 View all charges
Deals & funding
Curetech Formulations Private Limited has 1 deal on record (1 secondary share transfer); the latest was in December 2006.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2006 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Curetech Formulations Private Limited has 8 court cases on record: 4 filed by Curetech Formulations, 4 filed against it. 2 cases are pending and 6 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 3 | 1 |
| High courts | 3 | 0 | 1 |
| Supreme Court | 1 | 1 | 0 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, BENGALURU, Karnataka | Civil suit | Filed against the company by Bal Pharma Ltd | Disposed |
| High Court of Jharkhand | Court case (Cr.M.P.) | Filed by the company | Pending |
| District court, Solan, Himachal Pradesh | Cheque dishonour complaint | Filed by the company against M/S Inavars Biological Inc and 1 other | Pending |
| Supreme Court | Court case (1429-Criminal Matters : Matters for/against quashing of criminal proceedings) | Filed against the company by The State of Jharkhand Putli Bilung Drug Inspector Ranchi II, Office at District Food and Drug Contraol Ofifce, Sadar Hospital Campus, ,Ranchi , Jharkhand | Disposed |
| High Court, JHARKHAND | Court case (Cr.M.P.) | Filed by the company against The State of Jharkhand | Disposed |
To see the full case history of Curetech Formulations Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Curetech Formulations Private Limited was last rated by Brickwork on 13 Mar 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Brickwork | 13 Mar 2020 |
To see the full credit ratings and regulatory alerts of Curetech Formulations Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Curetech Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Curetech Formulations Private Limited has a workforce of 405 employees on its EPFO records as of May 2026, across 2 active EPFO establishments.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 405 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Curetech Formulations Private Limited, buy the company report.
GST
Curetech Formulations has 3 GST registrations: 2 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AACCC4441N1ZU | Himachal Pradesh | Active | 01 Jul 2017 |
| 02AACCC4441N2ZT | Himachal Pradesh | Active | 14 Jul 2017 |
To see the full GST registrations and return filing status of Curetech Formulations Private Limited, buy the company report.
Recent activity
Curetech Formulations Private Limited has 4 board changes on record since 2003: 2 appointments and 2 cessations. The latest: Ashwani Kumar ceased to be Managing Director on 01 Dec 2015.
50 earlier events are in the company report.
Frequently asked questions
Curetech Formulations is an active private limited company based in Shimla, Himachal Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 August 2003 (23+ years old) and is registered under CIN U24232HP2003PTC026326.
Curetech Formulations has 2 current directors:
- Sumit Kumar - Whole-Time Director
- Ashwani Kumar - Whole-Time Director
The latest financial statements of Curetech Formulations on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Curetech Formulations is 02AACCC4441N1ZU, registered in Himachal Pradesh. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 02AACCC4441N2ZT (Himachal Pradesh).
The CIN (Corporate Identification Number) of Curetech Formulations is U24232HP2003PTC026326. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Curetech Formulations has 8 court cases on record: 4 filed by the company and 4 filed against it. 2 are pending. Most are in the district courts.
Curetech Formulations was incorporated on 29 August 2003, making it 23+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.
Curetech Formulations has 1 deal on record (1 secondary share transfer); the latest was in December 2006.
The peers of Curetech Formulations by revenue are Nava Healthcare Private Limited, Inchem Laboratories Private Limited, Macmillon Pharmaceuticals Private Limited, Sunbeam Lifesciences Private Limited, Wexford Laboratories Private Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ashwani Kumar ceased to be Managing Director on 01 Dec 2015. Sumit Kumar ceased to be Director on 01 Dec 2015. Sumit Kumar was appointed as Whole-Time Director on 01 Aug 2006. Curetech Formulations has 4 board changes on record in total.
Yes, Curetech Formulations is registered as a medium enterprise under Udyam registration (number: UDYAM-HP-11-0001739).

